Project
Illumina Body Map 2: averaged replicates
Navigation
Downloads
Results for EBF1
Z-value: 2.69
Motif logo
Transcription factors associated with EBF1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
EBF1
|
ENSG00000164330.12 | EBF transcription factor 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| EBF1 | hg19_v2_chr5_-_158526756_158526797 | 0.28 | 1.2e-01 | Click! |
Activity profile of EBF1 motif
Sorted Z-values of EBF1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr22_+_23229960 | 7.68 |
ENST00000526893.1
ENST00000532223.2 ENST00000531372.1 |
IGLL5
|
immunoglobulin lambda-like polypeptide 5 |
| chr22_+_23101182 | 3.82 |
ENST00000390312.2
|
IGLV2-14
|
immunoglobulin lambda variable 2-14 |
| chr22_+_22697537 | 3.42 |
ENST00000427632.2
|
IGLV9-49
|
immunoglobulin lambda variable 9-49 |
| chr2_+_89890533 | 3.37 |
ENST00000429992.2
|
IGKV2D-40
|
immunoglobulin kappa variable 2D-40 |
| chr6_-_31550192 | 3.35 |
ENST00000429299.2
ENST00000446745.2 |
LTB
|
lymphotoxin beta (TNF superfamily, member 3) |
| chr22_-_23922410 | 3.24 |
ENST00000249053.3
|
IGLL1
|
immunoglobulin lambda-like polypeptide 1 |
| chr22_+_23154239 | 3.24 |
ENST00000390315.2
|
IGLV3-10
|
immunoglobulin lambda variable 3-10 |
| chr5_-_138725594 | 3.23 |
ENST00000302125.8
|
MZB1
|
marginal zone B and B1 cell-specific protein |
| chr22_+_23241661 | 3.14 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
| chr2_-_89327228 | 3.14 |
ENST00000483158.1
|
IGKV3-11
|
immunoglobulin kappa variable 3-11 |
| chr7_+_142494795 | 3.11 |
ENST00000390417.1
|
TRBJ2-5
|
T cell receptor beta joining 2-5 |
| chr22_-_23922448 | 3.01 |
ENST00000438703.1
ENST00000330377.2 |
IGLL1
|
immunoglobulin lambda-like polypeptide 1 |
| chr5_-_138725560 | 2.85 |
ENST00000412103.2
ENST00000457570.2 |
MZB1
|
marginal zone B and B1 cell-specific protein |
| chr14_-_106114739 | 2.80 |
ENST00000460164.1
|
RP11-731F5.2
|
RP11-731F5.2 |
| chr2_-_89385283 | 2.74 |
ENST00000390252.2
|
IGKV3-15
|
immunoglobulin kappa variable 3-15 |
| chr10_+_81370689 | 2.71 |
ENST00000372308.3
ENST00000398636.3 ENST00000428376.2 ENST00000372313.5 ENST00000419470.2 ENST00000429958.1 ENST00000439264.1 |
SFTPA1
|
surfactant protein A1 |
| chr22_+_23165153 | 2.53 |
ENST00000390317.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
| chr10_-_81320151 | 2.50 |
ENST00000372325.2
ENST00000372327.5 ENST00000417041.1 |
SFTPA2
|
surfactant protein A2 |
| chr7_+_142494920 | 2.46 |
ENST00000390418.1
|
TRBJ2-6
|
T cell receptor beta joining 2-6 |
| chr14_-_106758101 | 2.43 |
ENST00000390611.2
|
IGHV2-26
|
immunoglobulin heavy variable 2-26 |
| chr22_+_23134974 | 2.31 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
| chr5_+_176237478 | 2.30 |
ENST00000329542.4
|
UNC5A
|
unc-5 homolog A (C. elegans) |
| chr14_-_106331652 | 2.30 |
ENST00000390565.1
|
IGHJ1
|
immunoglobulin heavy joining 1 |
| chr22_+_23222886 | 2.27 |
ENST00000390319.2
|
IGLV3-1
|
immunoglobulin lambda variable 3-1 |
| chr17_+_37784749 | 2.26 |
ENST00000394265.1
ENST00000394267.2 |
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
| chr20_-_54580523 | 2.17 |
ENST00000064571.2
|
CBLN4
|
cerebellin 4 precursor |
| chr14_-_106174960 | 2.14 |
ENST00000390547.2
|
IGHA1
|
immunoglobulin heavy constant alpha 1 |
| chr22_+_23161491 | 2.12 |
ENST00000390316.2
|
IGLV3-9
|
immunoglobulin lambda variable 3-9 (gene/pseudogene) |
| chr16_+_22103828 | 2.07 |
ENST00000567131.1
ENST00000568328.1 ENST00000389398.5 ENST00000389397.4 |
VWA3A
|
von Willebrand factor A domain containing 3A |
| chr22_-_37640456 | 2.06 |
ENST00000405484.1
ENST00000441619.1 ENST00000406508.1 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
| chr22_+_22550113 | 2.03 |
ENST00000390285.3
|
IGLV6-57
|
immunoglobulin lambda variable 6-57 |
| chr7_-_100881041 | 1.99 |
ENST00000412417.1
ENST00000414035.1 |
CLDN15
|
claudin 15 |
| chr2_+_89986318 | 1.98 |
ENST00000491977.1
|
IGKV2D-29
|
immunoglobulin kappa variable 2D-29 |
| chr16_+_67679069 | 1.97 |
ENST00000545661.1
|
RLTPR
|
RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing |
| chr11_+_60223312 | 1.96 |
ENST00000532491.1
ENST00000532073.1 ENST00000534668.1 ENST00000528313.1 ENST00000533306.1 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
| chr19_+_42381337 | 1.96 |
ENST00000597454.1
ENST00000444740.2 |
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
| chr14_-_106725723 | 1.96 |
ENST00000390609.2
|
IGHV3-23
|
immunoglobulin heavy variable 3-23 |
| chr1_-_44497118 | 1.94 |
ENST00000537678.1
ENST00000466926.1 |
SLC6A9
|
solute carrier family 6 (neurotransmitter transporter, glycine), member 9 |
| chr8_-_22089533 | 1.88 |
ENST00000321613.3
|
PHYHIP
|
phytanoyl-CoA 2-hydroxylase interacting protein |
| chr11_+_60223225 | 1.87 |
ENST00000524807.1
ENST00000345732.4 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
| chr22_-_37640277 | 1.87 |
ENST00000401529.3
ENST00000249071.6 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
| chr11_-_111320706 | 1.87 |
ENST00000531398.1
|
POU2AF1
|
POU class 2 associating factor 1 |
| chr1_-_44497024 | 1.86 |
ENST00000372306.3
ENST00000372310.3 ENST00000475075.2 |
SLC6A9
|
solute carrier family 6 (neurotransmitter transporter, glycine), member 9 |
| chr19_+_42381173 | 1.86 |
ENST00000221972.3
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
| chr8_-_144241664 | 1.84 |
ENST00000342752.4
|
LY6H
|
lymphocyte antigen 6 complex, locus H |
| chr22_+_22681656 | 1.83 |
ENST00000390291.2
|
IGLV1-50
|
immunoglobulin lambda variable 1-50 (non-functional) |
| chr19_-_39108552 | 1.82 |
ENST00000591517.1
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
| chr8_-_144241432 | 1.81 |
ENST00000430474.2
|
LY6H
|
lymphocyte antigen 6 complex, locus H |
| chr22_+_22749343 | 1.80 |
ENST00000390298.2
|
IGLV7-43
|
immunoglobulin lambda variable 7-43 |
| chr7_+_142495131 | 1.79 |
ENST00000390419.1
|
TRBJ2-7
|
T cell receptor beta joining 2-7 |
| chr19_-_39108643 | 1.78 |
ENST00000396857.2
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
| chr14_+_106384295 | 1.73 |
ENST00000449410.1
ENST00000429431.1 |
KIAA0125
|
KIAA0125 |
| chr16_-_85146040 | 1.70 |
ENST00000539556.1
|
FAM92B
|
family with sequence similarity 92, member B |
| chr2_-_89476644 | 1.70 |
ENST00000484817.1
|
IGKV2-24
|
immunoglobulin kappa variable 2-24 |
| chr2_+_114163945 | 1.68 |
ENST00000453673.3
|
IGKV1OR2-108
|
immunoglobulin kappa variable 1/OR2-108 (non-functional) |
| chr19_+_17638059 | 1.67 |
ENST00000599164.1
ENST00000449408.2 ENST00000600871.1 ENST00000599124.1 |
FAM129C
|
family with sequence similarity 129, member C |
| chr2_+_90024732 | 1.66 |
ENST00000390268.2
|
IGKV2D-26
|
immunoglobulin kappa variable 2D-26 |
| chr19_-_50868882 | 1.65 |
ENST00000598915.1
|
NAPSA
|
napsin A aspartic peptidase |
| chr19_-_39108568 | 1.64 |
ENST00000586296.1
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
| chr14_-_106054659 | 1.61 |
ENST00000390539.2
|
IGHA2
|
immunoglobulin heavy constant alpha 2 (A2m marker) |
| chr14_-_106312010 | 1.60 |
ENST00000390556.2
|
IGHD
|
immunoglobulin heavy constant delta |
| chr22_+_22385332 | 1.59 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
| chr14_+_78870030 | 1.58 |
ENST00000553631.1
ENST00000554719.1 |
NRXN3
|
neurexin 3 |
| chr2_+_90458201 | 1.58 |
ENST00000603238.1
|
CH17-132F21.1
|
Uncharacterized protein |
| chr22_+_23040274 | 1.55 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
| chr7_-_100171270 | 1.54 |
ENST00000538735.1
|
SAP25
|
Sin3A-associated protein, 25kDa |
| chr15_-_74495188 | 1.54 |
ENST00000563965.1
ENST00000395105.4 |
STRA6
|
stimulated by retinoic acid 6 |
| chr2_+_90043607 | 1.54 |
ENST00000462693.1
|
IGKV2D-24
|
immunoglobulin kappa variable 2D-24 (non-functional) |
| chr19_+_49622646 | 1.54 |
ENST00000334186.4
|
PPFIA3
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 |
| chr14_-_106610852 | 1.53 |
ENST00000390603.2
|
IGHV3-15
|
immunoglobulin heavy variable 3-15 |
| chr12_-_49259643 | 1.53 |
ENST00000309739.5
|
RND1
|
Rho family GTPase 1 |
| chr17_-_34417479 | 1.52 |
ENST00000225245.5
|
CCL3
|
chemokine (C-C motif) ligand 3 |
| chr19_+_17638041 | 1.52 |
ENST00000601861.1
|
FAM129C
|
family with sequence similarity 129, member C |
| chr19_-_7766991 | 1.51 |
ENST00000597921.1
ENST00000346664.5 |
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23) |
| chr2_-_87088995 | 1.50 |
ENST00000393759.2
ENST00000349455.3 ENST00000331469.2 ENST00000431506.2 ENST00000393761.2 ENST00000390655.6 |
CD8B
|
CD8b molecule |
| chr2_-_89521942 | 1.50 |
ENST00000482769.1
|
IGKV2-28
|
immunoglobulin kappa variable 2-28 |
| chr22_+_22930626 | 1.48 |
ENST00000390302.2
|
IGLV2-33
|
immunoglobulin lambda variable 2-33 (non-functional) |
| chr2_+_89998789 | 1.47 |
ENST00000453166.2
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
| chr19_-_39104556 | 1.47 |
ENST00000423454.2
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
| chr22_+_23077065 | 1.47 |
ENST00000390310.2
|
IGLV2-18
|
immunoglobulin lambda variable 2-18 |
| chr17_+_7239904 | 1.46 |
ENST00000575425.1
|
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
| chr14_+_22204418 | 1.46 |
ENST00000390426.2
|
TRAV4
|
T cell receptor alpha variable 4 |
| chr14_-_106406090 | 1.43 |
ENST00000390593.2
|
IGHV6-1
|
immunoglobulin heavy variable 6-1 |
| chr14_+_22985251 | 1.40 |
ENST00000390510.1
|
TRAJ27
|
T cell receptor alpha joining 27 |
| chr4_-_5891918 | 1.38 |
ENST00000512574.1
|
CRMP1
|
collapsin response mediator protein 1 |
| chr14_-_106733624 | 1.38 |
ENST00000390610.2
|
IGHV1-24
|
immunoglobulin heavy variable 1-24 |
| chr4_-_87515202 | 1.37 |
ENST00000502302.1
ENST00000513186.1 |
MAPK10
|
mitogen-activated protein kinase 10 |
| chr1_-_156217829 | 1.37 |
ENST00000356983.2
ENST00000335852.1 ENST00000340183.5 ENST00000540423.1 |
PAQR6
|
progestin and adipoQ receptor family member VI |
| chr14_-_106573756 | 1.34 |
ENST00000390601.2
|
IGHV3-11
|
immunoglobulin heavy variable 3-11 (gene/pseudogene) |
| chr22_+_23264766 | 1.34 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
| chr7_+_24323782 | 1.34 |
ENST00000242152.2
ENST00000407573.1 |
NPY
|
neuropeptide Y |
| chr8_-_144242020 | 1.33 |
ENST00000414417.2
|
LY6H
|
lymphocyte antigen 6 complex, locus H |
| chr7_-_100881109 | 1.32 |
ENST00000308344.5
|
CLDN15
|
claudin 15 |
| chr22_+_22676808 | 1.32 |
ENST00000390290.2
|
IGLV1-51
|
immunoglobulin lambda variable 1-51 |
| chr12_+_120502441 | 1.32 |
ENST00000446727.2
|
CCDC64
|
coiled-coil domain containing 64 |
| chr22_+_22707260 | 1.31 |
ENST00000390293.1
|
IGLV5-48
|
immunoglobulin lambda variable 5-48 (non-functional) |
| chr11_-_10715502 | 1.31 |
ENST00000547195.1
|
MRVI1
|
murine retrovirus integration site 1 homolog |
| chr14_-_106963409 | 1.31 |
ENST00000390621.2
|
IGHV1-45
|
immunoglobulin heavy variable 1-45 |
| chr10_-_104179682 | 1.30 |
ENST00000406432.1
|
PSD
|
pleckstrin and Sec7 domain containing |
| chr7_+_142000747 | 1.30 |
ENST00000455382.2
|
TRBV2
|
T cell receptor beta variable 2 |
| chr17_+_7239821 | 1.30 |
ENST00000158762.3
ENST00000570457.2 |
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
| chr22_+_23235872 | 1.30 |
ENST00000390320.2
|
IGLJ1
|
immunoglobulin lambda joining 1 |
| chr14_-_107114267 | 1.30 |
ENST00000454421.2
|
IGHV3-64
|
immunoglobulin heavy variable 3-64 |
| chr19_+_17865011 | 1.29 |
ENST00000596462.1
ENST00000596865.1 ENST00000598960.1 ENST00000539407.1 |
FCHO1
|
FCH domain only 1 |
| chr2_+_177053307 | 1.29 |
ENST00000331462.4
|
HOXD1
|
homeobox D1 |
| chr2_+_150187020 | 1.29 |
ENST00000334166.4
|
LYPD6
|
LY6/PLAUR domain containing 6 |
| chr16_+_222846 | 1.28 |
ENST00000251595.6
ENST00000397806.1 |
HBA2
|
hemoglobin, alpha 2 |
| chr7_-_142659388 | 1.28 |
ENST00000476829.1
ENST00000467543.1 |
KEL
|
Kell blood group, metallo-endopeptidase |
| chr1_+_6086380 | 1.26 |
ENST00000602612.1
ENST00000378087.3 ENST00000341524.1 ENST00000352527.1 |
KCNAB2
|
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
| chr17_-_46507567 | 1.25 |
ENST00000584924.1
|
SKAP1
|
src kinase associated phosphoprotein 1 |
| chr14_-_100625932 | 1.25 |
ENST00000553834.1
|
DEGS2
|
delta(4)-desaturase, sphingolipid 2 |
| chr19_-_10628117 | 1.23 |
ENST00000333430.4
|
S1PR5
|
sphingosine-1-phosphate receptor 5 |
| chr19_-_38720294 | 1.23 |
ENST00000412732.1
ENST00000456296.1 |
DPF1
|
D4, zinc and double PHD fingers family 1 |
| chr1_-_156217875 | 1.22 |
ENST00000292291.5
|
PAQR6
|
progestin and adipoQ receptor family member VI |
| chr8_-_38006272 | 1.21 |
ENST00000522050.1
|
STAR
|
steroidogenic acute regulatory protein |
| chr13_-_41111323 | 1.21 |
ENST00000595486.1
|
AL133318.1
|
Uncharacterized protein |
| chr11_+_61520075 | 1.21 |
ENST00000278836.5
|
MYRF
|
myelin regulatory factor |
| chr2_-_89310012 | 1.20 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
| chr16_-_65155833 | 1.20 |
ENST00000566827.1
ENST00000394156.3 ENST00000562998.1 |
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast) |
| chr19_-_46998722 | 1.20 |
ENST00000377655.2
|
PNMAL2
|
paraneoplastic Ma antigen family-like 2 |
| chrX_+_129305623 | 1.19 |
ENST00000257017.4
|
RAB33A
|
RAB33A, member RAS oncogene family |
| chr7_+_76139925 | 1.18 |
ENST00000394849.1
|
UPK3B
|
uroplakin 3B |
| chr16_-_65155979 | 1.18 |
ENST00000562325.1
ENST00000268603.4 |
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast) |
| chr11_+_73676281 | 1.17 |
ENST00000543947.1
|
DNAJB13
|
DnaJ (Hsp40) homolog, subfamily B, member 13 |
| chr14_-_107199464 | 1.17 |
ENST00000433072.2
|
IGHV3-72
|
immunoglobulin heavy variable 3-72 |
| chr11_-_10715287 | 1.16 |
ENST00000423302.2
|
MRVI1
|
murine retrovirus integration site 1 homolog |
| chr2_+_89999259 | 1.15 |
ENST00000558026.1
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
| chr2_-_158300556 | 1.15 |
ENST00000264192.3
|
CYTIP
|
cytohesin 1 interacting protein |
| chr19_-_15575369 | 1.15 |
ENST00000343625.7
|
RASAL3
|
RAS protein activator like 3 |
| chr2_+_182322070 | 1.15 |
ENST00000233573.6
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) |
| chr9_-_34710066 | 1.14 |
ENST00000378792.1
ENST00000259607.2 |
CCL21
|
chemokine (C-C motif) ligand 21 |
| chr14_-_106781017 | 1.13 |
ENST00000390612.2
|
IGHV4-28
|
immunoglobulin heavy variable 4-28 |
| chr10_+_88718314 | 1.13 |
ENST00000348795.4
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1) |
| chr8_+_105352050 | 1.13 |
ENST00000297581.2
|
DCSTAMP
|
dendrocyte expressed seven transmembrane protein |
| chr6_-_32731243 | 1.12 |
ENST00000427449.1
ENST00000411527.1 |
HLA-DQB2
|
major histocompatibility complex, class II, DQ beta 2 |
| chr1_-_156217822 | 1.11 |
ENST00000368270.1
|
PAQR6
|
progestin and adipoQ receptor family member VI |
| chr16_-_67427389 | 1.11 |
ENST00000562206.1
ENST00000290942.5 ENST00000393957.2 |
TPPP3
|
tubulin polymerization-promoting protein family member 3 |
| chr5_+_148442844 | 1.11 |
ENST00000515519.1
|
CTC-529P8.1
|
CTC-529P8.1 |
| chr3_+_238969 | 1.10 |
ENST00000421198.1
|
CHL1
|
cell adhesion molecule L1-like |
| chr6_-_32731299 | 1.10 |
ENST00000435145.2
ENST00000437316.2 |
HLA-DQB2
|
major histocompatibility complex, class II, DQ beta 2 |
| chr11_+_6260298 | 1.10 |
ENST00000379936.2
|
CNGA4
|
cyclic nucleotide gated channel alpha 4 |
| chr20_-_43438912 | 1.10 |
ENST00000541604.2
ENST00000372851.3 |
RIMS4
|
regulating synaptic membrane exocytosis 4 |
| chr12_+_51818555 | 1.10 |
ENST00000453097.2
|
SLC4A8
|
solute carrier family 4, sodium bicarbonate cotransporter, member 8 |
| chr19_+_35606777 | 1.09 |
ENST00000604404.1
ENST00000435734.2 ENST00000603181.1 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
| chr7_+_76139833 | 1.07 |
ENST00000257632.5
|
UPK3B
|
uroplakin 3B |
| chr14_-_106331447 | 1.07 |
ENST00000390564.2
|
IGHJ2
|
immunoglobulin heavy joining 2 |
| chr11_+_129245796 | 1.07 |
ENST00000281437.4
|
BARX2
|
BARX homeobox 2 |
| chr11_+_111385497 | 1.06 |
ENST00000375618.4
ENST00000529167.1 ENST00000332814.6 |
C11orf88
|
chromosome 11 open reading frame 88 |
| chr3_-_112218205 | 1.06 |
ENST00000383680.4
|
BTLA
|
B and T lymphocyte associated |
| chr3_-_112218378 | 1.05 |
ENST00000334529.5
|
BTLA
|
B and T lymphocyte associated |
| chr11_-_107729504 | 1.05 |
ENST00000265836.7
|
SLC35F2
|
solute carrier family 35, member F2 |
| chr10_+_88718397 | 1.04 |
ENST00000372017.3
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1) |
| chr7_+_24324726 | 1.04 |
ENST00000405982.1
|
NPY
|
neuropeptide Y |
| chr6_-_31846744 | 1.04 |
ENST00000414427.1
ENST00000229729.6 ENST00000375562.4 |
SLC44A4
|
solute carrier family 44, member 4 |
| chr2_+_89901292 | 1.04 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
| chr16_-_15950868 | 1.03 |
ENST00000396324.3
ENST00000452625.2 ENST00000576790.2 ENST00000300036.5 |
MYH11
|
myosin, heavy chain 11, smooth muscle |
| chr1_+_159141397 | 1.03 |
ENST00000368124.4
ENST00000368125.4 ENST00000416746.1 |
CADM3
|
cell adhesion molecule 3 |
| chr17_-_42345487 | 1.03 |
ENST00000262418.6
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group) |
| chr11_-_107729287 | 1.03 |
ENST00000375682.4
|
SLC35F2
|
solute carrier family 35, member F2 |
| chr12_+_54402790 | 1.02 |
ENST00000040584.4
|
HOXC8
|
homeobox C8 |
| chr16_-_65156235 | 1.02 |
ENST00000564317.1
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast) |
| chr1_-_85462623 | 1.02 |
ENST00000370608.3
|
MCOLN2
|
mucolipin 2 |
| chr10_+_48355024 | 1.02 |
ENST00000395702.2
ENST00000442001.1 ENST00000433077.1 ENST00000436850.1 ENST00000494156.1 ENST00000586537.1 |
ZNF488
|
zinc finger protein 488 |
| chr22_-_37608325 | 1.02 |
ENST00000328544.3
|
SSTR3
|
somatostatin receptor 3 |
| chr14_-_24047965 | 1.02 |
ENST00000397118.3
ENST00000356300.4 |
JPH4
|
junctophilin 4 |
| chr7_-_98467489 | 1.01 |
ENST00000416379.2
|
TMEM130
|
transmembrane protein 130 |
| chr16_+_811073 | 1.01 |
ENST00000382862.3
ENST00000563651.1 |
MSLN
|
mesothelin |
| chr1_+_2407754 | 1.01 |
ENST00000419816.2
ENST00000378486.3 ENST00000378488.3 ENST00000288766.5 |
PLCH2
|
phospholipase C, eta 2 |
| chrX_+_70364667 | 1.00 |
ENST00000536169.1
ENST00000395855.2 ENST00000374051.3 ENST00000358741.3 |
NLGN3
|
neuroligin 3 |
| chr22_+_22781853 | 1.00 |
ENST00000390300.2
|
IGLV5-37
|
immunoglobulin lambda variable 5-37 |
| chr5_-_54468974 | 1.00 |
ENST00000381375.2
ENST00000296733.1 ENST00000322374.6 ENST00000334206.5 ENST00000331730.3 |
CDC20B
|
cell division cycle 20B |
| chrX_-_154493791 | 1.00 |
ENST00000369454.3
|
RAB39B
|
RAB39B, member RAS oncogene family |
| chr1_-_60539422 | 0.99 |
ENST00000371201.3
|
C1orf87
|
chromosome 1 open reading frame 87 |
| chr1_-_205649580 | 0.99 |
ENST00000367145.3
|
SLC45A3
|
solute carrier family 45, member 3 |
| chr12_-_50290839 | 0.99 |
ENST00000552863.1
|
FAIM2
|
Fas apoptotic inhibitory molecule 2 |
| chr14_-_75330537 | 0.99 |
ENST00000556084.2
ENST00000556489.2 ENST00000445876.1 |
PROX2
|
prospero homeobox 2 |
| chr12_+_51818586 | 0.99 |
ENST00000394856.1
|
SLC4A8
|
solute carrier family 4, sodium bicarbonate cotransporter, member 8 |
| chr12_+_54426637 | 0.97 |
ENST00000312492.2
|
HOXC5
|
homeobox C5 |
| chr2_-_75426826 | 0.97 |
ENST00000305249.5
|
TACR1
|
tachykinin receptor 1 |
| chr14_+_105953204 | 0.97 |
ENST00000409393.2
|
CRIP1
|
cysteine-rich protein 1 (intestinal) |
| chr1_-_60539405 | 0.97 |
ENST00000450089.2
|
C1orf87
|
chromosome 1 open reading frame 87 |
| chr1_-_226129083 | 0.96 |
ENST00000420304.2
|
LEFTY2
|
left-right determination factor 2 |
| chr19_-_7939319 | 0.96 |
ENST00000539422.1
|
CTD-3193O13.9
|
Protein FLJ22184 |
| chr1_-_26232522 | 0.96 |
ENST00000399728.1
|
STMN1
|
stathmin 1 |
| chr2_-_74645669 | 0.96 |
ENST00000518401.1
|
C2orf81
|
chromosome 2 open reading frame 81 |
| chr17_+_76126842 | 0.95 |
ENST00000590426.1
ENST00000590799.1 ENST00000318430.5 ENST00000589691.1 |
TMC8
|
transmembrane channel-like 8 |
| chr16_+_68678892 | 0.95 |
ENST00000429102.2
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
| chr9_-_117111222 | 0.95 |
ENST00000374079.4
|
AKNA
|
AT-hook transcription factor |
| chr17_-_37382105 | 0.95 |
ENST00000333461.5
|
STAC2
|
SH3 and cysteine rich domain 2 |
| chrX_+_118892545 | 0.95 |
ENST00000343905.3
|
SOWAHD
|
sosondowah ankyrin repeat domain family member D |
| chr14_-_107013465 | 0.95 |
ENST00000390625.2
|
IGHV3-49
|
immunoglobulin heavy variable 3-49 |
| chr12_-_132674229 | 0.95 |
ENST00000538731.1
|
RP13-977J11.2
|
RP13-977J11.2 |
| chr6_-_30899924 | 0.94 |
ENST00000359086.3
|
SFTA2
|
surfactant associated 2 |
| chr14_+_65878650 | 0.94 |
ENST00000555559.1
|
FUT8
|
fucosyltransferase 8 (alpha (1,6) fucosyltransferase) |
| chr11_-_119293903 | 0.94 |
ENST00000580275.1
|
THY1
|
Thy-1 cell surface antigen |
| chr1_-_156390128 | 0.92 |
ENST00000368242.3
|
C1orf61
|
chromosome 1 open reading frame 61 |
| chr2_+_98330009 | 0.92 |
ENST00000264972.5
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa |
| chr1_-_226129189 | 0.92 |
ENST00000366820.5
|
LEFTY2
|
left-right determination factor 2 |
| chr16_+_30194293 | 0.92 |
ENST00000561815.1
|
CORO1A
|
coronin, actin binding protein, 1A |
| chrX_-_20134990 | 0.92 |
ENST00000379651.3
ENST00000443379.3 ENST00000379643.5 |
MAP7D2
|
MAP7 domain containing 2 |
Network of associatons between targets according to the STRING database.
First level regulatory network of EBF1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.3 | 3.8 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 1.0 | 6.1 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.8 | 2.5 | GO:1904596 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
| 0.6 | 1.9 | GO:0050904 | diapedesis(GO:0050904) |
| 0.6 | 3.1 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.6 | 1.7 | GO:0048174 | negative regulation of short-term neuronal synaptic plasticity(GO:0048174) |
| 0.6 | 0.6 | GO:0035700 | astrocyte chemotaxis(GO:0035700) regulation of astrocyte chemotaxis(GO:2000458) |
| 0.5 | 1.0 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.5 | 2.5 | GO:0032796 | uropod organization(GO:0032796) |
| 0.5 | 1.4 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 0.4 | 1.3 | GO:0040040 | thermosensory behavior(GO:0040040) |
| 0.4 | 0.9 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 0.4 | 2.2 | GO:1903284 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
| 0.4 | 1.7 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.4 | 34.8 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.4 | 1.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.4 | 1.6 | GO:0002432 | granuloma formation(GO:0002432) |
| 0.4 | 1.6 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 0.4 | 1.1 | GO:0035759 | mesangial cell-matrix adhesion(GO:0035759) regulation of dendritic cell dendrite assembly(GO:2000547) |
| 0.4 | 3.3 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.4 | 4.1 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 0.4 | 2.1 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 0.4 | 1.1 | GO:0060827 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 0.3 | 1.0 | GO:0048925 | lateral line system development(GO:0048925) |
| 0.3 | 1.0 | GO:0021589 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.3 | 2.6 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
| 0.3 | 0.6 | GO:0016197 | endosomal transport(GO:0016197) |
| 0.3 | 1.6 | GO:1903615 | regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
| 0.3 | 1.6 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 0.3 | 0.9 | GO:0033037 | polysaccharide localization(GO:0033037) |
| 0.3 | 1.2 | GO:0034238 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
| 0.3 | 1.2 | GO:0018963 | phthalate metabolic process(GO:0018963) |
| 0.3 | 0.9 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.3 | 1.5 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.3 | 0.9 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.3 | 1.5 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.3 | 2.4 | GO:0045007 | depurination(GO:0045007) |
| 0.3 | 1.2 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
| 0.3 | 0.9 | GO:0006173 | dADP biosynthetic process(GO:0006173) |
| 0.3 | 0.9 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.3 | 2.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.3 | 1.4 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
| 0.3 | 0.8 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
| 0.3 | 1.1 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.3 | 31.6 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.3 | 0.8 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
| 0.3 | 1.8 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
| 0.3 | 0.8 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
| 0.3 | 0.5 | GO:0043385 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
| 0.3 | 0.5 | GO:0060557 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
| 0.3 | 1.5 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.3 | 1.3 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.3 | 2.5 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.3 | 0.8 | GO:1901076 | positive regulation of engulfment of apoptotic cell(GO:1901076) |
| 0.3 | 0.8 | GO:0031106 | septin ring assembly(GO:0000921) septin ring organization(GO:0031106) |
| 0.2 | 2.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.2 | 1.0 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.2 | 1.2 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.2 | 1.2 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 0.2 | 1.0 | GO:0032771 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 0.2 | 1.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.2 | 2.4 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 0.2 | 0.9 | GO:0021644 | vagus nerve morphogenesis(GO:0021644) |
| 0.2 | 1.7 | GO:0043129 | surfactant homeostasis(GO:0043129) |
| 0.2 | 0.9 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.2 | 0.2 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
| 0.2 | 0.7 | GO:0060596 | mammary placode formation(GO:0060596) |
| 0.2 | 1.4 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
| 0.2 | 2.3 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
| 0.2 | 0.9 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.2 | 1.5 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
| 0.2 | 0.7 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.2 | 1.5 | GO:0098704 | fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.2 | 0.9 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.2 | 1.3 | GO:0030421 | defecation(GO:0030421) |
| 0.2 | 0.8 | GO:0018277 | protein deamination(GO:0018277) |
| 0.2 | 0.8 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.2 | 0.6 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
| 0.2 | 1.0 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.2 | 2.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.2 | 1.6 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
| 0.2 | 3.3 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.2 | 3.9 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 0.2 | 1.0 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.2 | 0.8 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.2 | 0.2 | GO:0097102 | endothelial tip cell fate specification(GO:0097102) |
| 0.2 | 0.4 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.2 | 0.2 | GO:0090265 | positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) |
| 0.2 | 0.6 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.2 | 0.6 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 0.2 | 0.6 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.2 | 1.3 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.2 | 0.6 | GO:0060214 | endocardium formation(GO:0060214) |
| 0.2 | 1.1 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
| 0.2 | 0.2 | GO:0050707 | regulation of cytokine secretion(GO:0050707) negative regulation of cytokine secretion(GO:0050710) |
| 0.2 | 1.1 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.2 | 1.7 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.2 | 0.6 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) positive regulation of somatostatin secretion(GO:0090274) |
| 0.2 | 3.0 | GO:0055062 | phosphate ion homeostasis(GO:0055062) trivalent inorganic anion homeostasis(GO:0072506) |
| 0.2 | 1.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.2 | 0.9 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) interleukin-3-mediated signaling pathway(GO:0038156) |
| 0.2 | 0.5 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 0.2 | 0.2 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
| 0.2 | 2.8 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.2 | 0.2 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
| 0.2 | 1.2 | GO:0048619 | embryonic genitalia morphogenesis(GO:0030538) embryonic hindgut morphogenesis(GO:0048619) |
| 0.2 | 1.0 | GO:0043366 | beta selection(GO:0043366) |
| 0.2 | 0.7 | GO:0021836 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
| 0.2 | 0.5 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.2 | 1.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
| 0.2 | 0.8 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.2 | 5.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.2 | 0.8 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
| 0.2 | 0.6 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.2 | 1.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.2 | 0.5 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
| 0.1 | 0.6 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 0.1 | 0.9 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
| 0.1 | 0.9 | GO:0014028 | notochord formation(GO:0014028) |
| 0.1 | 0.4 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
| 0.1 | 0.4 | GO:2000657 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 0.1 | 0.7 | GO:0021586 | pons maturation(GO:0021586) |
| 0.1 | 0.4 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
| 0.1 | 0.3 | GO:0030100 | regulation of endocytosis(GO:0030100) |
| 0.1 | 0.4 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
| 0.1 | 1.5 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.1 | 0.3 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.1 | 0.6 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
| 0.1 | 0.7 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.1 | 28.9 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.1 | 0.4 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
| 0.1 | 1.2 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.1 | 0.9 | GO:0051785 | positive regulation of mitotic nuclear division(GO:0045840) positive regulation of nuclear division(GO:0051785) |
| 0.1 | 0.9 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.1 | 0.5 | GO:1903979 | negative regulation of microglial cell activation(GO:1903979) |
| 0.1 | 1.8 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 0.1 | 0.4 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.1 | 2.2 | GO:0035878 | nail development(GO:0035878) |
| 0.1 | 0.6 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.1 | 0.5 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
| 0.1 | 0.7 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
| 0.1 | 1.7 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.1 | 0.1 | GO:0042048 | olfactory behavior(GO:0042048) |
| 0.1 | 0.2 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.1 | 0.7 | GO:0021633 | optic nerve structural organization(GO:0021633) |
| 0.1 | 1.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.1 | 0.6 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 0.1 | 0.4 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.1 | 0.9 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.1 | 0.3 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
| 0.1 | 1.5 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.1 | 0.9 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.1 | 0.3 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.1 | 1.7 | GO:0015816 | glycine transport(GO:0015816) |
| 0.1 | 0.3 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.1 | 0.2 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
| 0.1 | 0.7 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
| 0.1 | 0.7 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.1 | 1.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.1 | 0.2 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.1 | 0.5 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.1 | 0.3 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.1 | 1.6 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.1 | 1.0 | GO:0003383 | apical constriction(GO:0003383) |
| 0.1 | 1.1 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 0.1 | 0.8 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.1 | 0.5 | GO:0060611 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 0.1 | 1.6 | GO:0021860 | pyramidal neuron development(GO:0021860) |
| 0.1 | 1.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.1 | 1.1 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
| 0.1 | 0.7 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 0.1 | 0.4 | GO:0060032 | notochord regression(GO:0060032) |
| 0.1 | 0.2 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
| 0.1 | 0.1 | GO:2000157 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.1 | 0.6 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.1 | 3.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 | 0.3 | GO:0002818 | intracellular defense response(GO:0002818) |
| 0.1 | 1.7 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
| 0.1 | 0.4 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.1 | 0.1 | GO:0003158 | endothelium development(GO:0003158) |
| 0.1 | 1.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.1 | 0.2 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
| 0.1 | 0.1 | GO:0043317 | regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
| 0.1 | 1.6 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 0.1 | 0.2 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.1 | 0.2 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
| 0.1 | 0.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.1 | 0.9 | GO:0008228 | opsonization(GO:0008228) |
| 0.1 | 0.5 | GO:2000537 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 0.1 | 0.4 | GO:0090128 | regulation of synapse maturation(GO:0090128) negative regulation of synapse maturation(GO:2000297) |
| 0.1 | 1.0 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.1 | 1.6 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.1 | 11.4 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.1 | 0.3 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.1 | 0.5 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.1 | 0.3 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.1 | 0.3 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.1 | 0.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.1 | 1.4 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.1 | 0.4 | GO:0097106 | postsynaptic density organization(GO:0097106) |
| 0.1 | 0.2 | GO:0001507 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
| 0.1 | 1.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 0.1 | 1.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.1 | 0.2 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
| 0.1 | 0.7 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 | 0.3 | GO:1902617 | tooth eruption(GO:0044691) response to fluoride(GO:1902617) |
| 0.1 | 0.1 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
| 0.1 | 0.6 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.1 | 0.4 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 0.1 | 2.2 | GO:0051412 | response to corticosterone(GO:0051412) |
| 0.1 | 0.3 | GO:1900737 | regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
| 0.1 | 6.8 | GO:0042100 | B cell proliferation(GO:0042100) |
| 0.1 | 0.4 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.1 | 0.6 | GO:0061055 | myotome development(GO:0061055) |
| 0.1 | 0.9 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 | 2.5 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 | 0.3 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.1 | 1.1 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.1 | 1.4 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.1 | 0.6 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.1 | 0.4 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) |
| 0.1 | 0.3 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 0.1 | 1.2 | GO:0099639 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
| 0.1 | 0.7 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.1 | 0.3 | GO:1900166 | glial cell-derived neurotrophic factor secretion(GO:0044467) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
| 0.1 | 1.3 | GO:1903012 | positive regulation of bone development(GO:1903012) |
| 0.1 | 1.0 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.1 | 0.2 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 0.1 | 3.3 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
| 0.1 | 0.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.1 | 0.6 | GO:0021592 | fourth ventricle development(GO:0021592) |
| 0.1 | 0.2 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
| 0.1 | 0.5 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.1 | 0.6 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
| 0.1 | 0.5 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.1 | 0.6 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.1 | 1.9 | GO:0045109 | intermediate filament organization(GO:0045109) |
| 0.1 | 0.9 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.1 | 0.3 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.1 | 0.9 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
| 0.1 | 0.9 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.1 | 0.5 | GO:1902075 | cellular response to salt(GO:1902075) |
| 0.1 | 0.8 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.1 | 0.2 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.1 | 0.7 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.1 | 0.3 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.1 | 0.2 | GO:1903450 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 0.1 | 0.2 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
| 0.1 | 5.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.1 | 0.6 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.1 | 1.3 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.1 | 0.3 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
| 0.1 | 0.3 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 0.1 | 1.1 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.1 | 0.1 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 0.1 | 1.4 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.1 | 0.6 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.1 | 1.3 | GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.1 | 0.2 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.1 | 0.3 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 0.1 | 0.8 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 0.1 | 1.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 | 2.2 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.1 | 2.3 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.1 | 0.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.1 | 0.1 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
| 0.1 | 0.2 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.1 | 0.3 | GO:0006813 | potassium ion transport(GO:0006813) |
| 0.1 | 1.0 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.1 | 0.7 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.1 | 0.4 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
| 0.1 | 0.2 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.1 | 0.5 | GO:0002223 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
| 0.1 | 0.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.1 | 0.1 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.1 | 1.3 | GO:0016322 | neuron remodeling(GO:0016322) |
| 0.1 | 0.4 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
| 0.1 | 0.3 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 | 0.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.1 | 0.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.1 | 0.7 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 | 0.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 | 0.5 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.1 | 0.2 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.1 | 2.1 | GO:0035640 | exploration behavior(GO:0035640) |
| 0.1 | 0.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 | 0.1 | GO:0061184 | Spemann organizer formation(GO:0060061) positive regulation of dermatome development(GO:0061184) |
| 0.1 | 0.2 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
| 0.1 | 0.5 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) cellular response to interleukin-2(GO:0071352) |
| 0.1 | 0.1 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
| 0.1 | 0.3 | GO:0046541 | saliva secretion(GO:0046541) |
| 0.1 | 1.3 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.1 | 0.2 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.1 | 0.2 | GO:0055073 | cadmium ion homeostasis(GO:0055073) |
| 0.1 | 0.3 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 0.1 | 0.5 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.1 | 1.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 | 0.2 | GO:0051445 | regulation of meiotic nuclear division(GO:0040020) negative regulation of meiotic nuclear division(GO:0045835) regulation of meiotic cell cycle(GO:0051445) negative regulation of meiotic cell cycle(GO:0051447) |
| 0.1 | 0.5 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 0.1 | 0.2 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.1 | 0.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.1 | 0.3 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.1 | 0.4 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
| 0.1 | 0.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.1 | 0.2 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 0.1 | 0.5 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.1 | 0.3 | GO:0007159 | leukocyte cell-cell adhesion(GO:0007159) |
| 0.1 | 0.3 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.1 | 0.8 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.1 | 0.5 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
| 0.1 | 0.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.1 | 0.5 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.1 | 0.2 | GO:0070859 | circadian temperature homeostasis(GO:0060086) positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
| 0.1 | 0.7 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.1 | 0.2 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.1 | 0.8 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.1 | 0.3 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
| 0.1 | 1.1 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.1 | 0.3 | GO:0070942 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
| 0.1 | 0.3 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 0.1 | 1.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 | 0.4 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
| 0.1 | 0.8 | GO:0010629 | negative regulation of gene expression(GO:0010629) |
| 0.1 | 0.2 | GO:0048565 | digestive tract development(GO:0048565) |
| 0.1 | 0.2 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
| 0.1 | 0.3 | GO:0080154 | regulation of fertilization(GO:0080154) |
| 0.1 | 0.6 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 | 1.4 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 | 0.3 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.1 | 0.5 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.1 | 0.9 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.1 | 0.4 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.1 | 1.8 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
| 0.0 | 2.6 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
| 0.0 | 0.8 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) peptidyl-threonine modification(GO:0018210) |
| 0.0 | 0.4 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
| 0.0 | 0.3 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.0 | 0.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.0 | 0.3 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.0 | 0.8 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.0 | 0.5 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.0 | 0.2 | GO:0003335 | corneocyte development(GO:0003335) |
| 0.0 | 0.1 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
| 0.0 | 0.4 | GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 0.0 | 0.7 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.0 | 0.1 | GO:0048611 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 0.0 | 0.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.0 | 0.5 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 0.0 | 0.0 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
| 0.0 | 0.2 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
| 0.0 | 0.1 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.0 | 0.4 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
| 0.0 | 1.2 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
| 0.0 | 0.3 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
| 0.0 | 0.3 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
| 0.0 | 0.1 | GO:1903463 | regulation of mitotic cell cycle DNA replication(GO:1903463) negative regulation of mitotic cell cycle DNA replication(GO:1903464) |
| 0.0 | 0.8 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.0 | 0.7 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.0 | 0.3 | GO:0046677 | response to antibiotic(GO:0046677) |
| 0.0 | 0.6 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
| 0.0 | 0.4 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
| 0.0 | 2.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.0 | 0.4 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.0 | 0.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.0 | 0.9 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
| 0.0 | 0.4 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.0 | 0.2 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.0 | 0.3 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.0 | 0.6 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.0 | 0.2 | GO:0016333 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.0 | 0.2 | GO:0052417 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
| 0.0 | 0.5 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.0 | 0.5 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.0 | 0.7 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.0 | 0.5 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.0 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.0 | 1.4 | GO:0048048 | embryonic eye morphogenesis(GO:0048048) |
| 0.0 | 0.3 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.0 | 4.5 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
| 0.0 | 0.2 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
| 0.0 | 0.2 | GO:0061074 | regulation of neural retina development(GO:0061074) |
| 0.0 | 0.1 | GO:0035038 | female pronucleus assembly(GO:0035038) |
| 0.0 | 0.2 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
| 0.0 | 2.1 | GO:0045576 | mast cell activation(GO:0045576) |
| 0.0 | 0.1 | GO:1902961 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.0 | 0.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 0.0 | 0.4 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.0 | 0.3 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.0 | 0.6 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.0 | 0.1 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
| 0.0 | 0.2 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.0 | 0.2 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.0 | 0.2 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
| 0.0 | 0.1 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.0 | 0.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.0 | 0.8 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
| 0.0 | 0.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.0 | 0.1 | GO:0021816 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
| 0.0 | 1.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
| 0.0 | 0.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.0 | 1.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.0 | 0.3 | GO:0030728 | ovulation(GO:0030728) |
| 0.0 | 0.1 | GO:0090647 | modulation of age-related behavioral decline(GO:0090647) regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 0.0 | 0.5 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.0 | 0.3 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.0 | 0.3 | GO:0001649 | osteoblast differentiation(GO:0001649) |
| 0.0 | 0.1 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.0 | 0.3 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.0 | 0.9 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.0 | 0.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.0 | 0.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.0 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.0 | 0.2 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.0 | 0.3 | GO:0021559 | trigeminal nerve development(GO:0021559) |
| 0.0 | 0.2 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.0 | 0.2 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
| 0.0 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.0 | 0.2 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.0 | 0.5 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.0 | 0.1 | GO:0097195 | pilomotor reflex(GO:0097195) |
| 0.0 | 0.1 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.0 | 0.5 | GO:1900115 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.0 | 0.3 | GO:0018212 | peptidyl-tyrosine phosphorylation(GO:0018108) peptidyl-tyrosine modification(GO:0018212) |
| 0.0 | 0.2 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.0 | 0.5 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 | 1.4 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.0 | 0.1 | GO:0021764 | amygdala development(GO:0021764) |
| 0.0 | 0.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.0 | 0.3 | GO:0031344 | regulation of cell projection organization(GO:0031344) |
| 0.0 | 0.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.0 | 0.6 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
| 0.0 | 0.3 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
| 0.0 | 0.8 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 | 0.3 | GO:0042428 | serotonin metabolic process(GO:0042428) |
| 0.0 | 0.2 | GO:0003352 | regulation of cilium movement(GO:0003352) |
| 0.0 | 0.2 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 0.0 | 0.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.0 | 0.4 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.0 | 0.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.0 | 0.5 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.0 | 0.4 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.0 | 1.0 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.0 | 0.2 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.0 | 0.7 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.0 | 0.2 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
| 0.0 | 0.3 | GO:0003341 | cilium movement(GO:0003341) |
| 0.0 | 0.4 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.0 | 0.2 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.0 | 0.2 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.0 | 1.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.0 | 0.3 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.0 | 0.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.0 | 0.4 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
| 0.0 | 0.0 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 0.0 | 0.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.0 | 0.5 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.0 | 0.9 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.0 | 0.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.0 | 0.5 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.0 | 0.7 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
| 0.0 | 0.3 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
| 0.0 | 0.7 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
| 0.0 | 0.1 | GO:0010899 | regulation of phosphatidylcholine catabolic process(GO:0010899) |
| 0.0 | 0.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
| 0.0 | 2.2 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
| 0.0 | 0.4 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
| 0.0 | 0.4 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 | 0.1 | GO:1900180 | regulation of protein localization to nucleus(GO:1900180) |
| 0.0 | 0.1 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.0 | 0.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.0 | 0.9 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
| 0.0 | 0.4 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
| 0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.0 | 0.2 | GO:0097435 | fibril organization(GO:0097435) |
| 0.0 | 0.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.0 | 0.2 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.0 | 0.1 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
| 0.0 | 0.4 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
| 0.0 | 0.6 | GO:0014003 | oligodendrocyte development(GO:0014003) |
| 0.0 | 0.1 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.0 | 0.4 | GO:0003351 | epithelial cilium movement(GO:0003351) |
| 0.0 | 0.7 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
| 0.0 | 0.4 | GO:0045730 | respiratory burst(GO:0045730) |
| 0.0 | 0.0 | GO:0030953 | astral microtubule organization(GO:0030953) |
| 0.0 | 0.2 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.0 | 0.2 | GO:1902219 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.0 | 0.1 | GO:1900274 | positive regulation of phospholipase C activity(GO:0010863) regulation of phospholipase C activity(GO:1900274) |
| 0.0 | 0.4 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
| 0.0 | 0.1 | GO:0033504 | floor plate development(GO:0033504) |
| 0.0 | 0.2 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.0 | 0.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.0 | 0.1 | GO:0090194 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
| 0.0 | 2.1 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
| 0.0 | 0.1 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
| 0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.0 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
| 0.0 | 0.2 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 0.0 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.0 | 0.7 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.0 | 0.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.0 | 0.2 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.0 | 0.2 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.0 | 0.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.0 | 0.1 | GO:0045144 | meiosis II(GO:0007135) meiotic sister chromatid segregation(GO:0045144) |
| 0.0 | 0.2 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
| 0.0 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.0 | 0.1 | GO:1990426 | homologous recombination-dependent replication fork processing(GO:1990426) |
| 0.0 | 0.1 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
| 0.0 | 0.2 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.0 | 0.0 | GO:0031297 | replication fork processing(GO:0031297) |
| 0.0 | 1.4 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) |
| 0.0 | 0.2 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
| 0.0 | 0.1 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.0 | 0.1 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.0 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 | 0.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.0 | 0.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.0 | 0.1 | GO:0030155 | regulation of cell adhesion(GO:0030155) |
| 0.0 | 0.4 | GO:0033280 | response to vitamin D(GO:0033280) |
| 0.0 | 0.1 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
| 0.0 | 0.3 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.0 | 0.4 | GO:0060325 | face morphogenesis(GO:0060325) |
| 0.0 | 0.1 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 0.0 | 0.5 | GO:0007130 | synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
| 0.0 | 0.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.0 | 0.1 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
| 0.0 | 0.2 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.0 | 0.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
| 0.0 | 0.1 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.0 | 0.3 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
| 0.0 | 0.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.0 | 0.3 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.0 | 0.4 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.0 | 0.1 | GO:0070649 | meiotic cytokinesis(GO:0033206) polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
| 0.0 | 0.3 | GO:0007254 | JNK cascade(GO:0007254) |
| 0.0 | 0.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 | 0.3 | GO:0000187 | activation of MAPK activity(GO:0000187) |
| 0.0 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.0 | 0.1 | GO:0051654 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) establishment of mitochondrion localization(GO:0051654) |
| 0.0 | 0.0 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 0.0 | 0.9 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
| 0.0 | 0.3 | GO:0007398 | ectoderm development(GO:0007398) |
| 0.0 | 0.2 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) |
| 0.0 | 1.2 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.0 | 1.7 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
| 0.0 | 0.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.0 | 0.3 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.0 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.0 | 0.0 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
| 0.0 | 0.1 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.0 | 0.1 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.0 | 0.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
| 0.0 | 0.2 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 | 0.3 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.0 | 0.2 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
| 0.0 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
| 0.0 | 0.3 | GO:0016572 | histone phosphorylation(GO:0016572) |
| 0.0 | 0.3 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.0 | 0.2 | GO:0071711 | basement membrane organization(GO:0071711) |
| 0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.0 | 0.0 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.0 | 0.3 | GO:0019054 | modulation by virus of host process(GO:0019054) |
| 0.0 | 0.3 | GO:0097186 | amelogenesis(GO:0097186) |
| 0.0 | 0.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.0 | 0.4 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
| 0.0 | 0.2 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.0 | 0.4 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.0 | 0.2 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 0.0 | 0.5 | GO:0035082 | axoneme assembly(GO:0035082) |
| 0.0 | 0.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
| 0.0 | 0.1 | GO:0032094 | response to food(GO:0032094) |
| 0.0 | 0.0 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.0 | 0.2 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
| 0.0 | 0.3 | GO:0032731 | positive regulation of interleukin-1 beta production(GO:0032731) |
| 0.0 | 0.3 | GO:0097421 | liver regeneration(GO:0097421) |
| 0.0 | 0.3 | GO:0019835 | cytolysis(GO:0019835) |
| 0.0 | 0.6 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.0 | 0.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 | 0.4 | GO:0007019 | microtubule depolymerization(GO:0007019) |
| 0.0 | 0.2 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.0 | 0.2 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.0 | 0.1 | GO:0002886 | regulation of myeloid leukocyte mediated immunity(GO:0002886) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.2 | 3.7 | GO:0071745 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
| 0.7 | 5.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.6 | 32.3 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.5 | 3.3 | GO:1990742 | microvesicle(GO:1990742) |
| 0.4 | 2.2 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.4 | 1.3 | GO:0097453 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
| 0.4 | 1.9 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.3 | 0.9 | GO:0030526 | granulocyte macrophage colony-stimulating factor receptor complex(GO:0030526) |
| 0.3 | 0.9 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
| 0.3 | 0.8 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 0.3 | 1.6 | GO:0097441 | basilar dendrite(GO:0097441) |
| 0.2 | 7.2 | GO:0042599 | lamellar body(GO:0042599) |
| 0.2 | 1.0 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 0.2 | 1.5 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.2 | 1.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.2 | 0.5 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
| 0.2 | 6.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.2 | 1.5 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.2 | 2.0 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
| 0.2 | 3.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.2 | 7.8 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.2 | 5.3 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.2 | 1.7 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
| 0.1 | 1.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.1 | 0.7 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.1 | 0.4 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.1 | 3.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.1 | 2.3 | GO:0070382 | exocytic vesicle(GO:0070382) |
| 0.1 | 0.4 | GO:0097179 | protease inhibitor complex(GO:0097179) |
| 0.1 | 0.4 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
| 0.1 | 0.3 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 0.1 | 0.5 | GO:0000811 | GINS complex(GO:0000811) |
| 0.1 | 0.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.1 | 0.7 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.1 | 0.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.1 | 1.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
| 0.1 | 0.7 |